To access this element change to forms mode OFF

Grant Award View - GA203593

OPN as an Immune Checkpoint in KRAS Mutant Colorectal Cancer

Contact Details

NHMRC Research Help Centre

:
1800500393

:

GA ID:
GA203593
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
1-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2023
Value (AUD):
$689,561.00 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
OPN as an Immune Checkpoint in KRAS Mutant Colorectal Cancer
Purpose:
Bowel cancer is a very common disease that will be diagnosed in 1/12 Australians living to age 85 and leads to over
4000 deaths annually. Subgrouping of colorectal cancers based on gene changes can predict response to therapy. Our research project specifically focuses on bowel cancers with a KRAS mutation that are usually resistant to currently available therapies. We are using cutting edge technology to identify novel approaches to therapy that will
improve outcomes for these patients.

GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2010319
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
The Council of the Queensland Institute of Medical Research
Recipient ABN:
31 411 813 344

Grant Recipient Location

Suburb:
Herston
Town/City:
Herston
Postcode:
4006
State/Territory:
QLD
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
ACT, QLD, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES

Contact Details

NHMRC Research Help Centre

:
1800500393

: